FNY Managed Accounts’s Exact Sciences EXAS Stock Holding History

FNY Managed Accounts’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-150	Closed	-$3K	–	304
2017 Q1	$3K	Buy	+150	New	+$2.97K	0.01%	678

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

FNY Managed Accounts's EXAS Position: Q2 2017 in Review

FNY Managed Accounts sold out of Exact Sciences (EXAS) in Q2 2017, closing a stake of 150 shares — an estimated $3K sold.

FNY Managed Accounts first reported a position in EXAS in Q1 2017 and held it in 1 quarter. The position peaked at $3K in Q1 2017. 266 funds tracked by Wall St. Rank hold EXAS as of Q2 2017.

FNY Managed Accounts reported no remaining Exact Sciences position as of Q2 2017 after selling out during the quarter.
FNY Managed Accounts sold 150 Exact Sciences shares in Q2 2017, an estimated $3K.
FNY Managed Accounts first reported a position in Exact Sciences in Q1 2017 and held it in 1 quarter.
FNY Managed Accounts's Exact Sciences position peaked at $3K in Q1 2017.
266 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2017.

Based on FNY Managed Accounts's 13F filing for Q2 2017, filed 10 Aug 2017.